CompletedPhase 2ketamine

Lamotrigine for Ketamine Dependence Trial

Sponsored by Taipei City Hospital

NCT ID
NCT02556060
Target Enrollment
30 participants
Start Date
2015-09
Est. Completion
2017-05-01

About This Study

The purpose of this study is to investigate the efficacy of lamotrigine in the treatment of ketamine dependence in a double-blind, placebo controlled design.

Conditions Studied

Addiction

Interventions

  • Lamotrigine
  • Placebo

Eligibility

Age:18 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

1. Current users of ketamine, including having a ketamine-positive urine
2. Meeting DSM-5 criteria for ketamine use disorder
3. Age between 18 to 65 years old
4. Women of childbearing age must have a negative pregnancy test to enroll in this study, agree to monthly pregnancy testing, and agree to use appropriate forms of birth control for the duration of the study.

Exclusion Criteria:

1. Significant medical conditions such as abnormal liver function or renal function confirmed by laboratory tests
2. Hypertension
3. A current cardiac condition or high risk of cardiovascular disease
4. Seizure disorders
5. Any another significant underlying medical condition which would contraindicate lamotrigine treatment
6. Meeting DSM-IV psychiatric classifications for schizophrenia, bipolar disorder, or other psychotic disorders
7. Meeting DSM-IV psychiatric classifications for substance use disorder other than ketamine within three month except tobacco or caffeine.
8. Exhibiting current suicidality or homicidality
9. Pregnant women, lactating women or women who are planning to be pregnant.

Study Locations (1)

Taipei City Hospital and Psychiatric Center
Taipei, Taiwan

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Lamotrigine for Ketamine Dependence Trial | Huxley